Wound healing modulators in a tracheoplasty canine model

Area of Science:

• Regenerative Medicine
• Surgical Innovation
• Biomaterials Science

Background:

• Postsurgical tracheal stenosis is a complication of fibrosis formation.
• Hyaluronic acid (HA) and collagen polyvinylpyrrolidone (CPVP) are known to modulate healing by reducing collagen fiber formation.
• Topical application of these modulators may prevent tracheal scarring and stenosis.

Purpose of the Study:

• To evaluate the effects of topical HA and CPVP on tracheal healing after surgery.
• To assess macroscopic, microscopic, and biochemical changes in a canine tracheoplasty model.
• To determine the efficacy of HA and CPVP in reducing postsurgical tracheal stenosis.

Main Methods:

• Prospective experimental investigation using a canine model with tracheal resection and anastomosis.
• Randomization into three groups: control (saline), HA treatment, and CPVP treatment.
• Clinical, radiological, endoscopic, and biochemical analyses of tracheal healing over 4 weeks, including collagen quantification.

Main Results:

• Control group exhibited significant tracheal stenosis, inflammation, and fibrosis.
• HA and CPVP groups demonstrated well-organized collagen fibers with minimal inflammation.
• Biochemical analysis confirmed higher collagen concentration in the control group compared to treatment groups.

Conclusions:

• Topical hyaluronic acid (HA) and collagen polyvinylpyrrolidone (CPVP) effectively diminish tracheal stenosis and inflammatory responses post-surgery.
• Both HA and CPVP significantly improve tracheal healing outcomes in a canine model.
• These findings suggest potential therapeutic benefits of HA and CPVP in preventing postsurgical tracheal complications.